OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacotherapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Update and narrative review of avian influenza (H5N1) infection in adult patients	91
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy	88
	63
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey	52
Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support	50
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect	42
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors	38
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	37
Warfarin dosage in a postpartum woman while breastfeeding: A case report	36
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy	34
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps	33
Comparison of risk‐scoring systems for heparin‐induced thrombocytopenia in cardiac surgery patients	33
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	30
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation	29
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant	27
	27
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency	26
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy	26
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy	26
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy	26
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”	25
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”	25
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse	24
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution	23
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn	23

Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures